A LARGE PRECISION MEDICINE CANCER INITIATIVE TO TEST THE EFFECTIVENESS OF TREATING ADULTS AND CHILDREN WITH NEW DRUG COMBINATIONS THAT TARGET SPECIFIC CANCEROUS TUMOR ALTERATIONS HAS LAUNCHED. KNOWN AS THE COMBINATION THERAPY PLATFORM TRIAL WITH MOLECULAR ANALYSIS FOR THERAPY CHOICE – OR ComboMATCH FOR SHORT -- THE INITIATIVE IS THE LARGEST OF ITS KIND TO TEST COMBINATIONS OF CANCER DRUGS GUIDED BY TUMOR BIOLOGY. DR. JEFFREY MOSCOW IN THE N-C-I’S DIVISION OF CANCER TREATMENT AND DIAGNOSIS SAYS THAT THE ENDEAVOR AIMS TO IDENTIFY PROMISING TREATMENTS THAT CAN ADVANCE TO LARGER, MORE DEFINITIVE CLINICAL TRIALS OUTSIDE OF COMBOMATCH.
Read MoreMuch progress has been made in treating people with melanoma that has spread in their bodies (metastatic melanoma). Yet many people still don't benefit from the newest drugs, and others may relapse after initially successful treatment. In this blog we will cover treatments and research being done in melanoma and other skin cancers.
Read More